mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age

mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age

Background: Vascular anomalies often result in aesthetic flaws, pain, and impair the quality of life. They require challenging treatments that frequently do not provide the desired results. The mammalian target of rapamycin (mTOR) is directly involved in the development of these malformations. Howev...

Full description

Bibliographic Details
Main Authors: Jakub Kopeć, Elżbieta Sałacińska-Łoś, Magdalena Orzechowska, Monika Sokolnicka, Aleksandra Gawłowska-Marciniak, Przewratil Przemysław
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Diagnostics
Subjects:
sirolimus
rapamycin
vascular anomalies
lymphatic malformation
venus malformation
mTOR
Online Access:https://www.mdpi.com/2075-4418/14/1/38

Internet

https://www.mdpi.com/2075-4418/14/1/38

Similar Items